Table 3.

Recommendations for Pneumococcal Immunization With PCV7 or 23PS Vaccine for Children at High Risk of Pneumococcal Disease, as Defined in Table 2

AgePrevious DosesRecommendations
≤23 moNonePCV7 as in Table 1
24–59 mo4 doses of PCV71 dose of 23PS vaccine at 24 mo, at least 6–8 wk after last dose of PCV7
1 dose of 23PS vaccine, 3–5 y after the first dose of 23PS vaccine
24–59 mo1–3 doses of PCV71 dose of PCV7
1 dose of 23PS vaccine, 6–8 wk after the last dose of PCV7
1 dose of 23PS vaccine, 3–5 y after the first dose of 23PS vaccine
24–59 mo1 dose of 23PS2 doses of PCV7, 6–8 wk apart, beginning at least 6–8 wk after last dose of 23PS vaccine
1 dose of 23PS vaccine, 3–5 y after the first dose of 23PS vaccine
24–59 moNone2 doses of PCV7 6–8 wk apart
1 dose of 23PS vaccine, 6–8 wk after the last dose of PCV7
1 dose of 23PS vaccine, 3–5 y after the first dose of 23PS vaccine
  • * Children with SCD, asplenia, HIV infection, and other high-risk factors.